摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[3-(4-hydroxy-phenyl)-propionyl]-glycine | 3850-43-9

中文名称
——
中文别名
——
英文名称
N-[3-(4-hydroxy-phenyl)-propionyl]-glycine
英文别名
N-[3-(4-Hydroxy-phenyl)-propionyl]-glycin;[β-(4-Oxy-phenyl)-propionyl]-glycin;3-(4-Hydroxyphenyl)propanoyl glycine;Phloretyl-glycin;Phloretylglycin;N-[(4-Hydroxybenzoyl)acetyl]glycine;2-[3-(4-hydroxyphenyl)propanoylamino]acetic acid
<i>N</i>-[3-(4-hydroxy-phenyl)-propionyl]-glycine化学式
CAS
3850-43-9
化学式
C11H13NO4
mdl
——
分子量
223.229
InChiKey
KPKFTTASECYTCL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    16
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    86.6
  • 氢给体数:
    3
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Bicycloheptane substituted diamide and its congener prostaglandin analogs
    申请人:E. R. Squibb & Sons, Inc.
    公开号:US04734424A1
    公开(公告)日:1988-03-29
    Bicycloheptane substituted amide prostaglandin analogs are provided having the structural formula ##STR1## wherein m is 0 to 4; A is --CH.dbd.CH-- or --CH.sub.2 --CH.sub.2 --; n is 1 to 5; Q is --CH.dbd.CH--, --CH.sub.2 --, ##STR2## or a single bond; R is CO.sub.2 H, CO.sub.2 alkyl, CO.sub.2 alkali metal, CO.sub.2 polyhydroxyamine salt, --CH.sub.2 OH, ##STR3## wherein R.sup.4 and R.sup.5 are the same or different and are H, lower alkyl, hydroxy, lower alkoxy or aryl, at least one of R.sup.4 and R.sup.5 being other than hydroxy and lower alkoxy; p is 1 to 4; R.sup.1 is H or lower alkyl; q is 1 to 12; R.sup.2 is H or lower alkyl; and R.sup.3 is H, lower alkyl, lower alkenyl, lower alkynyl, aryl, arylalkyl, lower alkoxy, aryloxy, arylalkyloxy, amino, alkylamino arylamino, arylalkylamino, lower alkyl-S-, aryl-S-, arylalkyl-S-, ##STR4## (wherein n' is 0, 1 or 2), alkylaminoalkyl, arylaminoalkyl, arylalkylaminoalkyl, alkoxyalkyl, aryloxyalkyl or arylalkoxyalkyl. The compounds are cardiovascular agents useful, for example, in the treatment of thrombotic disease.
    提供了具有结构式##STR1##的双环庚烷取代酰胺前列腺素类似物,其中m为0至4;A为--CH.dbd.CH--或--CH.sub.2 --CH.sub.2 --;n为1至5;Q为--CH.dbd.CH--,--CH.sub.2 --,##STR2##或单键;R为CO.sub.2 H,CO.sub.2烷基,CO.sub.2碱金属,CO.sub.2多羟胺盐,--CH.sub.2 OH,##STR3##其中R.sup.4和R.sup.5相同或不同,为H,低烷基,羟基,低烷氧基或芳基,R.sup.4和R.sup.5中至少有一个不是羟基和低烷氧基;p为1至4;R.sup.1为H或低烷基;q为1至12;R.sup.2为H或低烷基;R.sup.3为H,低烷基,低烯基,低炔基,芳基,芳基烷基,低烷氧基,芳氧基,芳基烷氧基,氨基,烷基氨基,芳基氨基,芳基烷基氨基,低烷基-S-,芳基-S-,芳基烷基-S-,##STR4##(其中n'为0,1或2),烷基氨基烷基,芳基氨基烷基,芳基烷基氨基烷基,烷氧基烷基,芳氧基烷基或芳基烷氧基。这些化合物是心血管药物,例如,在治疗血栓性疾病中有用。
  • 7-oxabicycloheptane substituted diamide and its congener prostaglandin
    申请人:E. R. Squibb & Sons, Inc.
    公开号:US04663336A1
    公开(公告)日:1987-05-05
    7-Oxabicycloheptane substituted amide prostaglandin analogs are provided having the structural formula ##STR1## wherein m is 0 to 4; A is --CH.dbd.CH-- or --CH.sub.2 --CH.sub.2 --; n is 1 to 5; Q is --CH.dbd.CH--, --CH.sub.2 --, ##STR2## or a single bond; R is CO.sub.2 H, CO.sub.2 alkyl, CO.sub.2 alkali metal, CO.sub.2 polyhydroxyamine salt, --CH.sub.2 OH, ##STR3## wherein R.sup.4 and R.sup.5 are the same or different and are H, lower alkyl, hydroxy, lower alkoxy or aryl, at least one of R.sup.4 and R.sup.5 being other than hydroxy and lower alkoxy; p is 1 to 4; R.sup.1 is H or lower alkyl; q is 1 to 12; R.sup.2 is H or lower alkyl; and R.sup.3 is H, lower alkyl, lower alkenyl, lower alkynyl, aryl, arylalkyl, lower alkoxy, aryloxy, arylalkyloxy, amino, alkylamino arylamino, arylalkylamino, ##STR4## (wherein n' is 0, 1 or 2), alkylaminoalkyl, arylaminoalkyl, arylalkylaminoalkyl, alkoxyalkyl, aryloxyalkyl or arylalkoxyalkyl. The compounds are cardiovascular agents useful, for example, in the treatment of thrombotic disease.
    提供了具有结构式##STR1##的7-氧代双环庚烷取代酰胺前列腺素类似物,其中m为0至4;A为--CH.dbd.CH--或--CH.sub.2 --CH.sub.2 --;n为1至5;Q为--CH.dbd.CH--,--CH.sub.2 --,##STR2##或单键;R为CO.sub.2 H,CO.sub.2烷基,CO.sub.2碱金属,CO.sub.2多羟胺盐,--CH.sub.2 OH,##STR3##其中R.sup.4和R.sup.5相同或不同,为H,低烷基,羟基,低烷氧基或芳基,R.sup.4和R.sup.5中至少有一个不是羟基和低烷氧基;p为1至4;R.sup.1为H或低烷基;q为1至12;R.sup.2为H或低烷基;R.sup.3为H,低烷基,低烯基,低炔基,芳基,芳基烷基,低烷氧基,芳氧基,芳基烷氧基,氨基,烷基氨基,芳基氨基,芳基烷基氨基,##STR4##(其中n'为0,1或2),烷基氨基烷基,芳基氨基烷基,芳基烷基氨基烷基,烷氧基烷基,芳氧基烷基或芳基烷氧基。这些化合物是心血管药物,例如,在治疗血栓性疾病方面有用。
  • 7-thiabicycloheptane substituted diamide and its congener prostaglandin
    申请人:E. R. Squibb & Sons, Inc.
    公开号:US04735962A1
    公开(公告)日:1988-04-05
    7-Thiabicycloheptane substituted diamide and congener prostaglandin analogs are provided having the structural formula ##STR1## wherein m is 1 to 4; A is --CH.dbd.CH-- or --CH.sub.2 --CH.sub.2 --; n is 1 to 5; R is CO.sub.2 H, CO.sub.2 alkyl, CO.sub.2 alkali metal, CO.sub.2 polyhydroxyamine salt, --CH.sub.2 OH, ##STR2## wherein R.sup.3 and R.sup.4 are the same or different and are H, lower alkyl, hydroxy, lower alkoxy or aryl, at least one of R.sup.3 and R.sup.4 being other than hydroxy and lower alkoxy; p is 1 to 4; Z is ##STR3## q is 1 to 12; R.sup.1 is H or lower alkyl; and R.sup.3 is H, lower alkyl, lower alkenyl, lower alkynyl, aryl, arylalkyl, lower alkoxy, aryloxy, arylalkyloxy, amino, alkylamino arylamino, arylalkylamino, ##STR4## (wherein n' is 0, 1 or 2), alkylaminoalkyl, arylaminoalkyl, arylalkylaminoalkyl, alkoxyalkyl, aryloxyalkyl or arylalkoxyalkyl. The compounds are cardiovascular agents useful, for example, in the treatment of thrombotic disease.
    提供了7-硫代双环庚烷取代二酰胺和同系物前列腺素类似物,其具有结构式##STR1##其中m为1至4;A为--CH.dbd.CH--或--CH.sub.2 --CH.sub.2 --;n为1至5;R为CO.sub.2 H,CO.sub.2烷基,CO.sub.2碱金属,CO.sub.2多羟胺盐,--CH.sub.2 OH,##STR2##其中R.sup.3和R.sup.4相同或不同,为H,低烷基,羟基,低烷氧基或芳基,R.sup.3和R.sup.4中至少有一个不是羟基和低烷氧基;p为1至4;Z为##STR3##q为1至12;R.sup.1为H或低烷基;R.sup.3为H,低烷基,低烯基,低炔基,芳基,芳基烷基,低烷氧基,芳氧基,芳基烷氧基,氨基,烷基氨基,芳基氨基,芳基烷基氨基,##STR4##(其中n'为0、1或2),烷基氨基烷基,芳基氨基烷基,芳基烷基氨基烷基,烷氧基烷基,芳氧基烷基或芳基烷氧基。这些化合物是心血管药物,例如,在治疗血栓性疾病中有用。
  • 5,6-epoxy-7-oxabicycloheptane substituted diamide prostaglandin analogs
    申请人:E. R. Squibb & Sons, Inc.
    公开号:US04734426A1
    公开(公告)日:1988-03-29
    5,6-Epoxy-7-oxabicycloheptane substituted diamide prostaglandin analogs are provided having the structural formula ##STR1## wherein A is --CH.dbd.CH-- or --CH.sub.2 --CH.sub.2 --; n is 1 to 5; R is CO.sub.2 H, CO.sub.2 alkyl, CO.sub.2 alkali metal, CO.sub.2 polyhydroxyamine salt or ##STR2## q is 1 to 12; and R.sup.1 is H, lower alkyl, lower alkenyl, lower alkynyl, aryl, arylalkyl, lower alkoxy, aryloxy, arylalkyloxy, amino, alkylamino arylamino, arylalkylamino, ##STR3## (wherein n' is 0, 1 or 2), alkylaminoalkyl, arylaminoalkyl, arylalkylaminoalkyl, alkoxyalkyl, aryloxyalkyl or arylalkoxyalkyl. The compounds are cardiovascular agents useful, for example, in the treatment of thrombotic disease.
    提供了具有结构式的5,6-环氧-7-氧代双胺前列腺素类似物的结构式,其中A为--CH.dbd.CH--或--CH.sub.2 --CH.sub.2 --;n为1至5;R为CO.sub.2 H,CO.sub.2 烷基,CO.sub.2 碱金属,CO.sub.2 多羟胺盐或q为1至12;R.sup.1为H,低烷基,低烯烃基,低炔基,芳基,芳基烷基,低烷氧基,芳氧基,芳基烷氧基,氨基,烷基氨基芳基氨基,芳基烷基氨基,(其中n'为0、1或2),烷基氨基烷基,芳基氨基烷基,芳基烷基氨基烷基,烷氧基烷基,芳氧基烷基或芳基烷氧基。这些化合物是心血管药物,例如,可用于治疗血栓性疾病。
  • NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE
    申请人:BISCHOFF Alexander
    公开号:US20090221583A1
    公开(公告)日:2009-09-03
    The present invention relates to piperazine derivatives that act as inhibitors of stearoyl-CoA desaturase. The invention also relates to methods of preparing the compounds, compositions containing the compounds, and to methods of treatment using the compounds.
    本发明涉及作为硬脂酰辅酶A去饱和酶抑制剂的吡啶二元衍生物。本发明还涉及制备该化合物的方法、含有该化合物的组合物以及使用该化合物进行治疗的方法。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物